Are you over 18 and want to see adult content?
More Annotations
CDS | Welcome to the Club Demonstration Services Home Page
Are you over 18 and want to see adult content?
KindredShop – Buy LoL Accounts and Smurfs | Unranked 30 LVL
Are you over 18 and want to see adult content?
Good Start Packaging | Compostable Food Packaging, Biodegradable Restaurant Supplies
Are you over 18 and want to see adult content?
Online Katapult | Gyakorlatias Online Bevételnövelő Eszköztár
Are you over 18 and want to see adult content?
DJI Mavic 2 Accessories & Tips | Mavic Help
Are you over 18 and want to see adult content?
Latest Aviation & Defense News Analysis: Indian Army, Navy, Air Force
Are you over 18 and want to see adult content?
Favourite Annotations
Ευκαιρίες Ακινήτων προς Πώληση - Ενοικίαση σε όλη την Ελλάδα
Are you over 18 and want to see adult content?
EdMyPic - All that you need for editing your photos online!
Are you over 18 and want to see adult content?
Dragon Ball Super VOSTFR - Tous les épisodes en Vostfr
Are you over 18 and want to see adult content?
Pharma GDD : Pharmacie en ligne, Parapharmacie
Are you over 18 and want to see adult content?
Unscripted360 - Sharing Useful Information For You
Are you over 18 and want to see adult content?
Text
NCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
ESCAPE OF SARS-COV-2 501Y.V2 VARIANTS FROM NEUTRALIZATION 1 Abstract 2 New SARS-CoV-2 variants with mutations in the spike glycoprotein have arisen inde- 3 pendently at multiple locations and may have functional signi cance. The combination 4 of mutations in the 501Y.V2 variant rst detected in South Africa include the N501Y, 5 K417N, and E484K mutations in the receptor binding domain (RBD) as well as muta- 6 tions in the N-terminal domain (NTD).TILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
ZAZA NDHLOVU
Dr Zaza Ndhlovu works on cellular immune responses to HIV-1, with the ultimate goal of finding a phenotypic target for an HIV vaccine. His research programme includes studies geared towards understanding initial events that contribute to immune dysfunction and subsequent disease progression. He uses excisional lymph node samples from acute and chronic HIV infected patientsJANET SEELEY
Janet Seeley. Professor Janet Seeley is a member of AHRI Faculty, and a Professor of Anthropology and Health at the London School of Hygiene and Tropical Medicine (LSHTM). A social anthropologist by training, over the past 35 years Janet has undertaken extended periods of research in Kenya, Uganda, Zambia, India, Nepal, Bangladesh, PakistanHENRIK KLØVERPRIS
Dr Henrik Kløverpris’ interest in HIV immunology first piqued at MSc level when, in 2005, he coordinated an HIV T-cell vaccine trial in Anders Fomsgaard’s lab at the Statens Serum Institute in Copenhagen, Denmark. In 2008 Henrik joined Philip Goulder’s lab at the University of Oxford to study the impact of T-cell responses incontrol
AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE Head: Human Capital . Wed, 09 06 2021 10:16:58 | Durban, KwaZulu-Natal | Negotiable. The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa and we are currently looking for a self-directed, highly motivated and reliable Head of Human Capital to join our fast pace Human Capital AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities. AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship betweenNCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
ESCAPE OF SARS-COV-2 501Y.V2 VARIANTS FROM NEUTRALIZATION 1 Abstract 2 New SARS-CoV-2 variants with mutations in the spike glycoprotein have arisen inde- 3 pendently at multiple locations and may have functional signi cance. The combination 4 of mutations in the 501Y.V2 variant rst detected in South Africa include the N501Y, 5 K417N, and E484K mutations in the receptor binding domain (RBD) as well as muta- 6 tions in the N-terminal domain (NTD).TILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
ZAZA NDHLOVU
Dr Zaza Ndhlovu works on cellular immune responses to HIV-1, with the ultimate goal of finding a phenotypic target for an HIV vaccine. His research programme includes studies geared towards understanding initial events that contribute to immune dysfunction and subsequent disease progression. He uses excisional lymph node samples from acute and chronic HIV infected patientsJANET SEELEY
Janet Seeley. Professor Janet Seeley is a member of AHRI Faculty, and a Professor of Anthropology and Health at the London School of Hygiene and Tropical Medicine (LSHTM). A social anthropologist by training, over the past 35 years Janet has undertaken extended periods of research in Kenya, Uganda, Zambia, India, Nepal, Bangladesh, PakistanHENRIK KLØVERPRIS
Dr Henrik Kløverpris’ interest in HIV immunology first piqued at MSc level when, in 2005, he coordinated an HIV T-cell vaccine trial in Anders Fomsgaard’s lab at the Statens Serum Institute in Copenhagen, Denmark. In 2008 Henrik joined Philip Goulder’s lab at the University of Oxford to study the impact of T-cell responses incontrol
TB RESEARCH MUST CONTINUE IN THE FACE OF THE COVID-19 TB remains a leading cause of death in South Africa. Despite it being a curable disease, an estimated 58 000 people died from TB in 2019 in the country. “The IDM and AHRI are at the forefront of cutting-edge research to solve the challenge of AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | ABOUT US | WORKING TOWARDS THE ELIMINATION OF HIV The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa. Our goal is to become a source of fundamental discoveries into the susceptibility, transmission and cure of HIV, TB and related diseases. AHRI LAUNCHES GROUND-BREAKING NEW RESEARCH PROGRAMME An innovative new Africa Health Research Institute (AHRI) programme is bringing cutting-edge health screening and scientific research to an area of northern KwaZulu-Natal with one of the highest HIV and tuberculosis prevalence rates in South Africa. Through the programme, AHRI hopes to get a better understanding of the ways in which the non-communicable and infectious ESCAPE OF SARS-COV-2 501Y.V2 VARIANTS FROM NEUTRALIZATION 1 Abstract 2 New SARS-CoV-2 variants with mutations in the spike glycoprotein have arisen inde- 3 pendently at multiple locations and may have functional signi cance. The combination 4 of mutations in the 501Y.V2 variant rst detected in South Africa include the N501Y, 5 K417N, and E484K mutations in the receptor binding domain (RBD) as well as muta- 6 tions in the N-terminal domain (NTD).ADRIE STEYN
Steyn Group. The main goal of Dr Adrie Steyn’s research group is to understand the mechanisms whereby Mycobacterium tuberculosis (M. tuberculosis) persist for decades without causing disease, to then suddenly explode.. M. tuberculosis is the bacterium that causes TB in the lungs. Despite years of investigation and research, scientists and health practitioners today are still struggling to TRIAL SHOWS UNIVERSAL ‘TEST AND TREAT’ POLICY ALONE IS NOT Results from a major five-year trial in South Africa show that rolling-out universal test and treat policy without innovation to better link people to treatment is unlikely to reduce the number of new HIV infections. The Treatment as Prevention (TasP) trail was run by the Africa Health Research Institute (AHRI) in partnership with theFrench
RAVI GUPTA | AFRICA HEALTH RESEARCH INSTITUTE Ravi Gupta. Professor Ravindra Gupta is an AHRI Faculty member and a Professor of Clinical Microbiology at the Cambridge Institute for Therapeutic Immunology and Infectious Diseases. In 2020, Ravi was named as one of TIME’s 100 most influential people of 2020 . Ravi initially trained as a clinical infectious diseases physician and wenton to
ANRS 12249 TASP PROTOCOL Abstract • TasP ANRS 12249 Protocol - 6 - acceptability and feasibility rather than HIV incidence. If results from the first phase indicate acceptability and feasibility, the trial will be rolled-outto the other
NIGEL KLEIN
Nigel Klein. Professor Nigel Klein is a member of AHRI Faculty. He is Professor and Consultant in Paediatric Infectious Diseases and Immunology at Great Ormond Street Children’s Hospital, London, and the Institute of Child Health, University College London (UCL). He trained at UCL and has degrees in Anatomy and in Medicine. AHRI | WORKING TOWARDS THE ELIMINATION OF HIV AND TB DISEASEABOUTRESEARCHEDUCATIONPUBLIC ENGAGEMENTCAREERSAHRI STRUCTURE &GOVERNANCE
Nceba Gqaleni. Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | POSTGRADUATE RESEARCH PhD Programme. AHRI is always looking for outstanding and innovative students with a background in social, biological, mathematical, chemical and/or engineering science to join its PhD Programme. Access to a world-class research facility. Weekly tutorials with Faculty on advanced topics in HIV and TB. Reserved places on AHRI Short Courses. AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities.AHRI | CONTACT US
General Enquiries. info@ahri.org. Durban: +27 (0)31 260 4991. Somkhele: +27 (0)35 550 7500. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE AHRI offers a wide range of career opportunities within various disciplines. These include nursing (research), clinical research, basic science research, immunology, pharmacology, biorepository, social science and epidemiology research, statistics, data management and analysis, information technology and security, human resources,finance and
NCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship between ESCAPE OF SARS-COV-2 501Y.V2 VARIANTS FROM NEUTRALIZATION 1 Abstract 2 New SARS-CoV-2 variants with mutations in the spike glycoprotein have arisen inde- 3 pendently at multiple locations and may have functional signi cance. The combination 4 of mutations in the 501Y.V2 variant rst detected in South Africa include the N501Y, 5 K417N, and E484K mutations in the receptor binding domain (RBD) as well as muta- 6 tions in the N-terminal domain (NTD). EMILY WONG | AFRICA HEALTH RESEARCH INSTITUTE Emily Wong. Dr Emily Wong is an Infectious Disease physician-scientist whose work focuses on trying to understand the impact of HIV infection on TB pathogenesis, immunity and epidemiology. To address these questions she uses a range of techniques that span molecular to population science. Emily specialises in establishing unique humancohorts
AHRI | WORKING TOWARDS THE ELIMINATION OF HIV AND TB DISEASEABOUTRESEARCHEDUCATIONPUBLIC ENGAGEMENTCAREERSAHRI STRUCTURE &GOVERNANCE
Nceba Gqaleni. Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | POSTGRADUATE RESEARCH PhD Programme. AHRI is always looking for outstanding and innovative students with a background in social, biological, mathematical, chemical and/or engineering science to join its PhD Programme. Access to a world-class research facility. Weekly tutorials with Faculty on advanced topics in HIV and TB. Reserved places on AHRI Short Courses. AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities.AHRI | CONTACT US
General Enquiries. info@ahri.org. Durban: +27 (0)31 260 4991. Somkhele: +27 (0)35 550 7500. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE AHRI offers a wide range of career opportunities within various disciplines. These include nursing (research), clinical research, basic science research, immunology, pharmacology, biorepository, social science and epidemiology research, statistics, data management and analysis, information technology and security, human resources,finance and
NCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship between ESCAPE OF SARS-COV-2 501Y.V2 VARIANTS FROM NEUTRALIZATION 1 Abstract 2 New SARS-CoV-2 variants with mutations in the spike glycoprotein have arisen inde- 3 pendently at multiple locations and may have functional signi cance. The combination 4 of mutations in the 501Y.V2 variant rst detected in South Africa include the N501Y, 5 K417N, and E484K mutations in the receptor binding domain (RBD) as well as muta- 6 tions in the N-terminal domain (NTD). EMILY WONG | AFRICA HEALTH RESEARCH INSTITUTE Emily Wong. Dr Emily Wong is an Infectious Disease physician-scientist whose work focuses on trying to understand the impact of HIV infection on TB pathogenesis, immunity and epidemiology. To address these questions she uses a range of techniques that span molecular to population science. Emily specialises in establishing unique humancohorts
AHRI | ABOUT US | WORKING TOWARDS THE ELIMINATION OF HIV The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa. Our goal is to become a source of fundamental discoveries into the susceptibility, transmission and cure of HIV, TB and related diseases.AHRI | OUR RESEARCH
AHRI is an independent, transdisciplinary scientific research institute. AHRI’s research combines population, basic, social, and medical sciences to understand and intervene in the health and well-being of South African communities. Research at AHRI is led by a Faculty of 18 scientists, each of whom heads up their own researchgroup.
AHRI | POSTGRADUATE RESEARCH PhD Programme. AHRI is always looking for outstanding and innovative students with a background in social, biological, mathematical, chemical and/or engineering science to join its PhD Programme. Access to a world-class research facility. Weekly tutorials with Faculty on advanced topics in HIV and TB. Reserved places on AHRI Short Courses.AHRI | CONTACT US
General Enquiries. info@ahri.org. Durban: +27 (0)31 260 4991. Somkhele: +27 (0)35 550 7500. ESCAPE OF SARS-COV-2 501Y.V2 VARIANTS FROM NEUTRALIZATION 1 Abstract 2 New SARS-CoV-2 variants with mutations in the spike glycoprotein have arisen inde- 3 pendently at multiple locations and may have functional signi cance. The combination 4 of mutations in the 501Y.V2 variant rst detected in South Africa include the N501Y, 5 K417N, and E484K mutations in the receptor binding domain (RBD) as well as muta- 6 tions in the N-terminal domain (NTD). NEW RESEARCH TRACES ORIGINS OF DRUG RESISTANT TB TO THE The emergence of drug resistance is threatening the control of tuberculosis in South Africa and other parts of the world. Researchers from K-RITH and the Broad Institute of MIT and Harvard have traced the roots of extensively drug-resistant TB (XDR TB) in KwaZulu-Natal (KZN) to the late 1950s. Their findings, published in the journal PLOSADRIE STEYN
Steyn Group. The main goal of Dr Adrie Steyn’s research group is to understand the mechanisms whereby Mycobacterium tuberculosis (M. tuberculosis) persist for decades without causing disease, to then suddenly explode.. M. tuberculosis is the bacterium that causes TB in the lungs. Despite years of investigation and research, scientists and health practitioners today are still struggling toTILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
HENRIK KLØVERPRIS
Dr Henrik Kløverpris’ interest in HIV immunology first piqued at MSc level when, in 2005, he coordinated an HIV T-cell vaccine trial in Anders Fomsgaard’s lab at the Statens Serum Institute in Copenhagen, Denmark. In 2008 Henrik joined Philip Goulder’s lab at the University of Oxford to study the impact of T-cell responses incontrol
AHRI POLICY AND PROCEDURE FOR INVESTIGATING ALLEGATIONS … 6 Investigation: formal development of a factual record and the examination of that record leading either to a decision not to make a finding of scientific misconduct, or a recommendation for a finding of scientific misconduct which may include a recommendation for other appropriate actions. AHRI | WORKING TOWARDS THE ELIMINATION OF HIV AND TB DISEASEABOUTRESEARCHEDUCATIONPUBLIC ENGAGEMENTCAREERSAHRI STRUCTURE &GOVERNANCE
Dr Maryam Shahmanesh. Dr Maryam Shahmanesh's research interests lie in the interdisciplinary space between social science, clinical medicine and epidemiology. She enjoys using innovative and participatory methods to develop and rapidly evaluate complex interventions that improve the health of adolescents, youth and marginalised populations. AHRI | ABOUT US | WORKING TOWARDS THE ELIMINATION OF HIVEDUCATIONOUR RESEARCHCONTACTMARYAM SHAHMANESHMOHLOPHENI MARAKALALA The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa. Our goal is to become a source of fundamental discoveries into the susceptibility, transmission and cure of HIV, TB and related diseases. AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE AHRI offers a wide range of career opportunities within various disciplines. These include nursing (research), clinical research, basic science research, immunology, pharmacology, biorepository, social science and epidemiology research, statistics, data management and analysis, information technology and security, human resources,finance and
AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship betweenNCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
TILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
JANET SEELEY
Janet Seeley. Professor Janet Seeley is a member of AHRI Faculty, and a Professor of Anthropology and Health at the London School of Hygiene and Tropical Medicine (LSHTM). A social anthropologist by training, over the past 35 years Janet has undertaken extended periods of research in Kenya, Uganda, Zambia, India, Nepal, Bangladesh, Pakistan AHRI | WORKING TOWARDS THE ELIMINATION OF HIV AND TB DISEASEABOUTRESEARCHEDUCATIONPUBLIC ENGAGEMENTCAREERSAHRI STRUCTURE &GOVERNANCE
Dr Maryam Shahmanesh. Dr Maryam Shahmanesh's research interests lie in the interdisciplinary space between social science, clinical medicine and epidemiology. She enjoys using innovative and participatory methods to develop and rapidly evaluate complex interventions that improve the health of adolescents, youth and marginalised populations. AHRI | ABOUT US | WORKING TOWARDS THE ELIMINATION OF HIVEDUCATIONOUR RESEARCHCONTACTMARYAM SHAHMANESHMOHLOPHENI MARAKALALA The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa. Our goal is to become a source of fundamental discoveries into the susceptibility, transmission and cure of HIV, TB and related diseases. AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE AHRI offers a wide range of career opportunities within various disciplines. These include nursing (research), clinical research, basic science research, immunology, pharmacology, biorepository, social science and epidemiology research, statistics, data management and analysis, information technology and security, human resources,finance and
AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship betweenNCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
TILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
JANET SEELEY
Janet Seeley. Professor Janet Seeley is a member of AHRI Faculty, and a Professor of Anthropology and Health at the London School of Hygiene and Tropical Medicine (LSHTM). A social anthropologist by training, over the past 35 years Janet has undertaken extended periods of research in Kenya, Uganda, Zambia, India, Nepal, Bangladesh, PakistanMARK SIEDNER
Mark Siedner. Dr. Mark Siedner is an infectious diseases specialist and clinical epidemiologist. His clinical and research work is focussed on decreasing the burden of infectious diseases on health and quality of life. Mark also has a passion for transferring these AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa.AHRI | CONTACT US
General Enquiries. info@ahri.org. Durban: +27 (0)31 260 4991. Somkhele: +27 (0)35 550 7500. NEW RESEARCH TRACES ORIGINS OF DRUG RESISTANT TB TO THE The emergence of drug resistance is threatening the control of tuberculosis in South Africa and other parts of the world. Researchers from K-RITH and the Broad Institute of MIT and Harvard have traced the roots of extensively drug-resistant TB (XDR TB) in KwaZulu-Natal (KZN) to the late 1950s. Their findings, published in the journal PLOS WORLD-LEADING TB EXPERT APPOINTED NEW DIRECTOR OF AFRICA The Africa Health Research Institute (AHRI) is pleased to announce Professor Willem Hanekom as its new Director, following an extensive international search process. Professor Hanekom (pictured above) is a clinician-scientist and a world-leading expert in tuberculosis vaccine development. He joins AHRI from the Bill & Melinda Gates Foundation, where he was a Deputy Director inADRIE STEYN
Steyn Group. The main goal of Dr Adrie Steyn’s research group is to understand the mechanisms whereby Mycobacterium tuberculosis (M. tuberculosis) persist for decades without causing disease, to then suddenly explode.. M. tuberculosis is the bacterium that causes TB in the lungs. Despite years of investigation and research, scientists and health practitioners today are still struggling toTILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
MARK SIEDNER
Mark Siedner. Dr. Mark Siedner is an infectious diseases specialist and clinical epidemiologist. His clinical and research work is focussed on decreasing the burden of infectious diseases on health and quality of life. Mark also has a passion for transferring these AHRI POLICY AND PROCEDURE FOR INVESTIGATING ALLEGATIONS … 6 Investigation: formal development of a factual record and the examination of that record leading either to a decision not to make a finding of scientific misconduct, or a recommendation for a finding of scientific misconduct which may include a recommendation for other appropriate actions. EMILY WONG | AFRICA HEALTH RESEARCH INSTITUTE Emily Wong. Dr Emily Wong is an Infectious Disease physician-scientist whose work focuses on trying to understand the impact of HIV infection on TB pathogenesis, immunity and epidemiology. To address these questions she uses a range of techniques that span molecular to population science. Emily specialises in establishing unique humancohorts
ANRS 12249 TASP PROTOCOL Abstract • TasP ANRS 12249 Protocol - 6 - acceptability and feasibility rather than HIV incidence. If results from the first phase indicate acceptability and feasibility, the trial will be rolled-outto the other
AHRI | WORKING TOWARDS THE ELIMINATION OF HIV AND TB DISEASEABOUTRESEARCHEDUCATIONPUBLIC ENGAGEMENTCAREERSAHRI STRUCTURE &GOVERNANCE
Dr Maryam Shahmanesh. Dr Maryam Shahmanesh's research interests lie in the interdisciplinary space between social science, clinical medicine and epidemiology. She enjoys using innovative and participatory methods to develop and rapidly evaluate complex interventions that improve the health of adolescents, youth and marginalised populations. AHRI | ABOUT US | WORKING TOWARDS THE ELIMINATION OF HIVEDUCATIONOUR RESEARCHCONTACTMARYAM SHAHMANESHMOHLOPHENI MARAKALALA The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa. Our goal is to become a source of fundamental discoveries into the susceptibility, transmission and cure of HIV, TB and related diseases. AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE AHRI offers a wide range of career opportunities within various disciplines. These include nursing (research), clinical research, basic science research, immunology, pharmacology, biorepository, social science and epidemiology research, statistics, data management and analysis, information technology and security, human resources,finance and
AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship betweenNCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
TILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
JANET SEELEY
Janet Seeley. Professor Janet Seeley is a member of AHRI Faculty, and a Professor of Anthropology and Health at the London School of Hygiene and Tropical Medicine (LSHTM). A social anthropologist by training, over the past 35 years Janet has undertaken extended periods of research in Kenya, Uganda, Zambia, India, Nepal, Bangladesh, PakistanMARK SIEDNER
Mark Siedner. Dr. Mark Siedner is an infectious diseases specialist and clinical epidemiologist. His clinical and research work is focussed on decreasing the burden of infectious diseases on health and quality of life. Mark also has a passion for transferring these AHRI | WORKING TOWARDS THE ELIMINATION OF HIV AND TB DISEASEABOUTRESEARCHEDUCATIONPUBLIC ENGAGEMENTCAREERSAHRI STRUCTURE &GOVERNANCE
Dr Maryam Shahmanesh. Dr Maryam Shahmanesh's research interests lie in the interdisciplinary space between social science, clinical medicine and epidemiology. She enjoys using innovative and participatory methods to develop and rapidly evaluate complex interventions that improve the health of adolescents, youth and marginalised populations. AHRI | ABOUT US | WORKING TOWARDS THE ELIMINATION OF HIVEDUCATIONOUR RESEARCHCONTACTMARYAM SHAHMANESHMOHLOPHENI MARAKALALA The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa. Our goal is to become a source of fundamental discoveries into the susceptibility, transmission and cure of HIV, TB and related diseases. AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE AHRI offers a wide range of career opportunities within various disciplines. These include nursing (research), clinical research, basic science research, immunology, pharmacology, biorepository, social science and epidemiology research, statistics, data management and analysis, information technology and security, human resources,finance and
AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship betweenNCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
TILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
JANET SEELEY
Janet Seeley. Professor Janet Seeley is a member of AHRI Faculty, and a Professor of Anthropology and Health at the London School of Hygiene and Tropical Medicine (LSHTM). A social anthropologist by training, over the past 35 years Janet has undertaken extended periods of research in Kenya, Uganda, Zambia, India, Nepal, Bangladesh, PakistanMARK SIEDNER
Mark Siedner. Dr. Mark Siedner is an infectious diseases specialist and clinical epidemiologist. His clinical and research work is focussed on decreasing the burden of infectious diseases on health and quality of life. Mark also has a passion for transferring these AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa.AHRI | CONTACT US
General Enquiries. info@ahri.org. Durban: +27 (0)31 260 4991. Somkhele: +27 (0)35 550 7500. NEW RESEARCH TRACES ORIGINS OF DRUG RESISTANT TB TO THE The emergence of drug resistance is threatening the control of tuberculosis in South Africa and other parts of the world. Researchers from K-RITH and the Broad Institute of MIT and Harvard have traced the roots of extensively drug-resistant TB (XDR TB) in KwaZulu-Natal (KZN) to the late 1950s. Their findings, published in the journal PLOS WORLD-LEADING TB EXPERT APPOINTED NEW DIRECTOR OF AFRICA The Africa Health Research Institute (AHRI) is pleased to announce Professor Willem Hanekom as its new Director, following an extensive international search process. Professor Hanekom (pictured above) is a clinician-scientist and a world-leading expert in tuberculosis vaccine development. He joins AHRI from the Bill & Melinda Gates Foundation, where he was a Deputy Director inADRIE STEYN
Steyn Group. The main goal of Dr Adrie Steyn’s research group is to understand the mechanisms whereby Mycobacterium tuberculosis (M. tuberculosis) persist for decades without causing disease, to then suddenly explode.. M. tuberculosis is the bacterium that causes TB in the lungs. Despite years of investigation and research, scientists and health practitioners today are still struggling toTILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
MARK SIEDNER
Mark Siedner. Dr. Mark Siedner is an infectious diseases specialist and clinical epidemiologist. His clinical and research work is focussed on decreasing the burden of infectious diseases on health and quality of life. Mark also has a passion for transferring these AHRI POLICY AND PROCEDURE FOR INVESTIGATING ALLEGATIONS … 6 Investigation: formal development of a factual record and the examination of that record leading either to a decision not to make a finding of scientific misconduct, or a recommendation for a finding of scientific misconduct which may include a recommendation for other appropriate actions. EMILY WONG | AFRICA HEALTH RESEARCH INSTITUTE Emily Wong. Dr Emily Wong is an Infectious Disease physician-scientist whose work focuses on trying to understand the impact of HIV infection on TB pathogenesis, immunity and epidemiology. To address these questions she uses a range of techniques that span molecular to population science. Emily specialises in establishing unique humancohorts
ANRS 12249 TASP PROTOCOL Abstract • TasP ANRS 12249 Protocol - 6 - acceptability and feasibility rather than HIV incidence. If results from the first phase indicate acceptability and feasibility, the trial will be rolled-outto the other
AHRI | WORKING TOWARDS THE ELIMINATION OF HIV AND TB DISEASEABOUTRESEARCHEDUCATIONPUBLIC ENGAGEMENTCAREERSAHRI STRUCTURE &GOVERNANCE
Dr Maryam Shahmanesh. Dr Maryam Shahmanesh's research interests lie in the interdisciplinary space between social science, clinical medicine and epidemiology. She enjoys using innovative and participatory methods to develop and rapidly evaluate complex interventions that improve the health of adolescents, youth and marginalised populations. AHRI | ABOUT US | WORKING TOWARDS THE ELIMINATION OF HIVEDUCATIONOUR RESEARCHCONTACTMARYAM SHAHMANESHMOHLOPHENI MARAKALALA The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa. Our goal is to become a source of fundamental discoveries into the susceptibility, transmission and cure of HIV, TB and related diseases. AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE AHRI offers a wide range of career opportunities within various disciplines. These include nursing (research), clinical research, basic science research, immunology, pharmacology, biorepository, social science and epidemiology research, statistics, data management and analysis, information technology and security, human resources,finance and
AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship betweenNCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
TILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
JANET SEELEY
Janet Seeley. Professor Janet Seeley is a member of AHRI Faculty, and a Professor of Anthropology and Health at the London School of Hygiene and Tropical Medicine (LSHTM). A social anthropologist by training, over the past 35 years Janet has undertaken extended periods of research in Kenya, Uganda, Zambia, India, Nepal, Bangladesh, PakistanMARK SIEDNER
Mark Siedner. Dr. Mark Siedner is an infectious diseases specialist and clinical epidemiologist. His clinical and research work is focussed on decreasing the burden of infectious diseases on health and quality of life. Mark also has a passion for transferring these AHRI | WORKING TOWARDS THE ELIMINATION OF HIV AND TB DISEASEABOUTRESEARCHEDUCATIONPUBLIC ENGAGEMENTCAREERSAHRI STRUCTURE &GOVERNANCE
Dr Maryam Shahmanesh. Dr Maryam Shahmanesh's research interests lie in the interdisciplinary space between social science, clinical medicine and epidemiology. She enjoys using innovative and participatory methods to develop and rapidly evaluate complex interventions that improve the health of adolescents, youth and marginalised populations. AHRI | ABOUT US | WORKING TOWARDS THE ELIMINATION OF HIVEDUCATIONOUR RESEARCHCONTACTMARYAM SHAHMANESHMOHLOPHENI MARAKALALA The Africa Health Research Institute (AHRI) is a multidisciplinary, independent research institute based across two sites in the province of KwaZulu-Natal, South Africa. Our goal is to become a source of fundamental discoveries into the susceptibility, transmission and cure of HIV, TB and related diseases. AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa. AHRI | PUBLIC & COMMUNITY ENGAGEMENT AHRI’s public and community engagement model encourages people to be active partners in the development of a research agenda that is meaningful and directly relevant to their lives. The AHRI Somkhele Community Advisory Board (CAB) is a vital component of this, and acts as a ‘bridge’ to our research communities. CAREERS | AFRICA HEALTH RESEARCH INSTITUTE AHRI offers a wide range of career opportunities within various disciplines. These include nursing (research), clinical research, basic science research, immunology, pharmacology, biorepository, social science and epidemiology research, statistics, data management and analysis, information technology and security, human resources,finance and
AHRI HOSTS RECORDING OF BBC WORLD SERVICE’S ‘THE EVIDENCE Africa Health Research Institute (AHRI) recently hosted the recording for one of the 2018 episodes of BBC World Service’s ‘The Evidence’. In The Evidence, radio presenter Claudia Hammond joins scientists and experts to explore the effect science has on the world around us. The focus of the episode recorded at AHRI was the relationship betweenNCEBA GQALENI
Professor Nceba Gqaleni’s role at AHRI is to develop a traditional/natural medicine programme. His aim is to help fast-track the research and development of traditional medicines against Covid-19, HIV and non-communicable diseases. He also leads on policy engagement at the Institute. Nceba has experience in research on African traditional medicines against HIV/Aids and immunomodulation.He
TILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
JANET SEELEY
Janet Seeley. Professor Janet Seeley is a member of AHRI Faculty, and a Professor of Anthropology and Health at the London School of Hygiene and Tropical Medicine (LSHTM). A social anthropologist by training, over the past 35 years Janet has undertaken extended periods of research in Kenya, Uganda, Zambia, India, Nepal, Bangladesh, PakistanMARK SIEDNER
Mark Siedner. Dr. Mark Siedner is an infectious diseases specialist and clinical epidemiologist. His clinical and research work is focussed on decreasing the burden of infectious diseases on health and quality of life. Mark also has a passion for transferring these AHRI/UCL PHD STUDENTSHIP 2021 AHRI/UCL PhD Studentship 2021 – 2022. Applications are open for the 2021 – 2022 Africa Health Research Institute/UCL PhD Studentship. This opportunity covers tuition fees and living costs to undertake a PhD at UCL. It is funded by UCL’s Division of Infection and Immunity and is open to applicants who permanently reside in South Africa.AHRI | CONTACT US
General Enquiries. info@ahri.org. Durban: +27 (0)31 260 4991. Somkhele: +27 (0)35 550 7500. NEW RESEARCH TRACES ORIGINS OF DRUG RESISTANT TB TO THE The emergence of drug resistance is threatening the control of tuberculosis in South Africa and other parts of the world. Researchers from K-RITH and the Broad Institute of MIT and Harvard have traced the roots of extensively drug-resistant TB (XDR TB) in KwaZulu-Natal (KZN) to the late 1950s. Their findings, published in the journal PLOS WORLD-LEADING TB EXPERT APPOINTED NEW DIRECTOR OF AFRICA The Africa Health Research Institute (AHRI) is pleased to announce Professor Willem Hanekom as its new Director, following an extensive international search process. Professor Hanekom (pictured above) is a clinician-scientist and a world-leading expert in tuberculosis vaccine development. He joins AHRI from the Bill & Melinda Gates Foundation, where he was a Deputy Director inADRIE STEYN
Steyn Group. The main goal of Dr Adrie Steyn’s research group is to understand the mechanisms whereby Mycobacterium tuberculosis (M. tuberculosis) persist for decades without causing disease, to then suddenly explode.. M. tuberculosis is the bacterium that causes TB in the lungs. Despite years of investigation and research, scientists and health practitioners today are still struggling toTILL BÄRNIGHAUSEN
Professor Till Bärnighausen is a member of AHRI Faculty, holds an Alexander von Humboldt Professorship and is the Director of the Institute of Public Health in the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Harvard T.H. Chan School of Public Health. Till previously workedas
MARK SIEDNER
Mark Siedner. Dr. Mark Siedner is an infectious diseases specialist and clinical epidemiologist. His clinical and research work is focussed on decreasing the burden of infectious diseases on health and quality of life. Mark also has a passion for transferring these AHRI POLICY AND PROCEDURE FOR INVESTIGATING ALLEGATIONS … 6 Investigation: formal development of a factual record and the examination of that record leading either to a decision not to make a finding of scientific misconduct, or a recommendation for a finding of scientific misconduct which may include a recommendation for other appropriate actions. EMILY WONG | AFRICA HEALTH RESEARCH INSTITUTE Emily Wong. Dr Emily Wong is an Infectious Disease physician-scientist whose work focuses on trying to understand the impact of HIV infection on TB pathogenesis, immunity and epidemiology. To address these questions she uses a range of techniques that span molecular to population science. Emily specialises in establishing unique humancohorts
ANRS 12249 TASP PROTOCOL Abstract • TasP ANRS 12249 Protocol - 6 - acceptability and feasibility rather than HIV incidence. If results from the first phase indicate acceptability and feasibility, the trial will be rolled-outto the other
Get the latest news and information from government on COVID-19 inSouth Africa here
AHRI TB HIV RESEARCH* About
* About AHRI
* AHRI Structure & Governance* News
* Contact
* Research
* Our Research
* People
* Publications
* Policy Briefs
* Education
* Education & Training * Connect Africa Scholarships * Internship Programme * Postgraduate Research* Public Engagement
* Careers
__
* About
* About AHRI
* AHRI Structure & Governance* News
* Contact
* Research
* Our Research
* People
* Publications
* Policy Briefs
* Education
* Education & Training * Connect Africa Scholarships * Internship Programme * Postgraduate Research* Public Engagement
* Careers
* Adrie Steyn
* Al Leslie
* Alex Sigal
* Alison Grant
* Emily Wong
* Frank Tanser
* Henrik Kløverpris* Janet Seeley
* Kobus Herbst
* Mark Siedner
* Maryam Shahmanesh
* Mohlopheni Marakalala* Nceba Gqaleni
* Nigel Klein
* Ravi Gupta
* Thumbi Ndung’u
* Till Bärnighausen* Zaza Ndhlovu
OPTIMAL HEALTH AND
WELL-BEING OF UNDER- RESOURCED POPULATIONSAHRI NEWS
INNOVATIVE COLLABORATION LEADS TO NEW INSIGHTS INTO TB IMMUNE RESPONSE17.05.2021 Research
AHRI CELEBRATES TWO NEW PHD GRADUATES30.04.2021 Research
COVID-19 VARIANT 501Y.V2 IS CROSS PROTECTIVE 29.03.2021 Research View more LOOKING FOR SOMETHINGIN PARTICULAR?
* Tell me more about AHRI * I’m interested in your research * Take me to your publications MEET THE AHRI SCIENTISTS PROFESSOR FRANK TANSER Professor Frank Tanser is a South African scientist whose research aims to evaluate and design intervention strategies to drive back the HIV epidemic and its negative consequences in communities hardest hit by the epidemic. His pivotal work over the past 20 years has provided substantial insights into the evolving and dynamic nature of the HIV epidemic and its key drivers, informing HIV prevention and treatment efforts in sub-S...Tell me more
*
*
* © 2021 AHRI
* Contact Us
* Privacy Policy
* Policy on scientific misconduct* AHRI PAIA manual
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0